Status:
RECRUITING
Assessment of Quality of Life After Low Anterior Resection During Cytoreductive Surgery for Advanced Ovarian Cancer
Lead Sponsor:
Seoul National University Hospital
Conditions:
Ovarian Cancer
Low Anterior Resection Syndrome
Eligibility:
FEMALE
18+ years
Brief Summary
This study aims to evaluate the incidence of low anterior resection syndrome and quality of life after cytoreductive surgery for advanced ovarian cancer patients.
Detailed Description
In advanced ovarian cancer, 24-64% of patients require removal of tumors located in the rectum and sigmoid colon. In order to remove the tumor located in the rectum and sigmoid colon, low anterior res...
Eligibility Criteria
Inclusion
- Those with newly diagnosed ovarian cancer, fallopian tube cancer and primary peritoneal carcinomatosis who plan to undergo cytoreductive surgery and secondary cytoreductive surgery after neoadjuvant chemotherapy.
- Patients with PCDS or rectal and sigmoid coloni tumor invasion suspected on the preoperative image and need resection of the tumor and clinical FIGO stage IIIB or higher
- ECOG performance status : 0-2
- Age over 18
Exclusion
- Patient who underwent low anterior resection in the past
- Past history of gastrointestinal malignant tumor except to ovarian cancer
- Patient who have colostomy
- Patient who underwent radiation therapy to abdominal or pelvic cavity
- ECOG performance status over 3
- Patient taking opioid analgesics
- Patient who have intellectual disability or dementia
Key Trial Info
Start Date :
June 22 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2027
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT05431530
Start Date
June 22 2022
End Date
May 31 2027
Last Update
June 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 03080